TY  - JOUR

T1  - ATLANTIS: a randomised multi-arm phase II biomarker-directed umbrella screening trial of maintenance targeted therapy after chemotherapy in patients with advanced or metastatic urothelial cancer

JO  - Trials

PY  - 2020/04/19

AU  - Fulton B

AU  - Jones R

AU  - Powles T

AU  - Crabb S

AU  - Paul J

AU  - Birtle A

AU  - Chowdhury S

AU  - Hussain S

AU  - Morris A

AU  - Soulis E

AU  - Morrison P

ED  - 

DO  - DOI: 10.1186/s13063-020-04283-5

PB  - BioMed Central

VL  - 21

Y2  - 2024/12/22

ER  -